Category Health Tech

Regeneron Wins Antitrust Case Against Amgen, Safeguarding Biotech Innovation and Patient Access to Life-Saving PCSK9 Therapies

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a significant legal victory after a jury in the U.S. District Court for the District of Delaware ruled that Amgen Inc. violated multiple antitrust…

Read MoreRegeneron Wins Antitrust Case Against Amgen, Safeguarding Biotech Innovation and Patient Access to Life-Saving PCSK9 Therapies